US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CNBX Pharmaceuticals Inc.

0.0004

0.0000-11.11%

Volume:19.62M

Turnover:8.00K

Market Cap:221.60K

PE:-0.12

High:0.0005

Open:0.0004

Low:0.0004

Close:0.0005

52wk High:0.0157

52wk Low:0.0002

Shares:554.00M

Float Shares:91.79M

Volume Ratio:0.75

T/O Rate:21.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0035

EPS(LYR):-0.0035

ROE:-4289.36%

ROA:-681.68%

PB:-0.09

PE(LYR):-0.12

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CNBX Pharmaceuticals Inc.

Exchange:

PINK

Establishment Date:

2004

Employees:

1

Office Location:

#3 Bethesda Metro Center,Suite 700,Bethesda,Maryland,United States

Website:

http://www.cannabics.com

Zip Code:

20814

Phone:

Fax:

- -

Introduction:

CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNBX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNBX\",,,,,undefined,":{"symbol":"CNBX","market":"US","secType":"STK","nameCN":"CNBX Pharmaceuticals Inc.","latestPrice":0.0004,"timestamp":1764968400000,"preClose":0.00045,"halted":0,"volume":19622925,"delay":15,"floatShares":91785600,"shares":554000000,"eps":-0.003463,"marketStatus":"Market Closed","change":-0.00005,"latestTime":"12-05 16:00:00 EST Delay","open":0.0004,"high":0.0005,"low":0.0004,"amount":8001.689900000001,"amplitude":0.222222,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.003463,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.00045,"volumeRatio":0.7530353334344532},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNBX\",,,,,undefined,":{"symbol":"CNBX","floatShares":91785600,"roa":"-681.68%","roe":"-4289.36%","lyrEps":-0.003463,"volumeRatio":0.7530353334344532,"shares":554000000,"dividePrice":0,"high":0.0005,"amplitude":0.222222,"preClose":0.00045,"low":0.0004,"week52Low":0.0002,"pbRate":"-0.09","week52High":0.0157,"institutionHeld":0,"latestPrice":0.0004,"eps":-0.003463,"divideRate":0,"volume":19622925,"delay":15,"ttmEps":-0.003463,"open":0.0004,"prevYearClose":0.0074,"prevWeekClose":0.0004,"prevMonthClose":0.0004,"prevQuarterClose":0.0003,"fiveDayClose":0.0004,"twentyDayClose":0.0003,"sixtyDayClose":0.0003},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-07-15","symbol":"CNBX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1721016000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-01-12","symbol":"CNBX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1705035600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-29","symbol":"CNBX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1701234000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-05-12","symbol":"CNBX","defaultRemindTime":1652362200000,"type":"split","dateTimestamp":1652328000000,"forFactor":1000000,"toFactor":8333,"ratio":120.00480019200768}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNBX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":130738072,"yearFounded":2004,"employeeNum":1,"address":"#3 Bethesda Metro Center,Suite 700,Bethesda,Maryland,United States","zipCode":"20814","officePhone":"877 424 2429"},"stockCompanyDetail":{"websiteUrl":"http://www.cannabics.com","stockEarnings":[{"period":"1week","weight":0.1398},{"period":"1month","weight":0.0778},{"period":"3month","weight":-0.21},{"period":"6month","weight":-0.2942},{"period":"1year","weight":-0.6515},{"period":"ytd","weight":-0.1828}],"description":"CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland.","exchange":"PINK","name":"CNBX Pharmaceuticals Inc.","nameEN":"CNBX Pharmaceuticals Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CNBX\",market:\"US\",,,undefined,":null}}